Iowa Senate Bill SSB3101

Iowa 2023-2024 Regular Session

• Introduced: 1/23/24
• Refer: 1/23/24

Caption

A bill for an act relating to the regulation of vapor products, and providing penalties.(See SF 2402.)

Impact

The introduction of this legislation will have significant implications for how vapor products are marketed and sold in Iowa. By requiring a compliance directory, the state aims to improve oversight and reduce the availability of unregulated or non-compliant products in the market. This could potentially impact retailers and distributors, who will need to ensure that their inventory adheres to the new requirements. Furthermore, the bill specifies that revenues from fees and penalties related to vapor products will contribute to the health care trust fund, thereby intertwining health care funding with regulatory enforcement.

Summary

Senate Study Bill 3101 addresses the regulation of vapor products within the state of Iowa. The legislation requires all vapor products sold in the state to be included in a newly established vapor products directory. Manufacturers must certify compliance under penalty of perjury, providing evidence of marketing authorization from the FDA or prior marketing in the U.S. as of August 8, 2016. The bill stipulates that non-compliant products can face seizure and destruction, enhancing the regulatory framework surrounding vapor products and their manufacturers.

Contention

Notably, there might be contention regarding the enforcement mechanisms outlined in the bill, which impose civil penalties on manufacturers, retailers, and distributors for violations. For instance, a manufacturer whose products are not listed can incur a hefty civil penalty of $1,000 per day until compliance is achieved. Additionally, the requirement for annual compliance checks could raise concerns over operational feasibility for smaller businesses. Critics may argue that these stringent regulations could disproportionately affect small manufacturers and impede market competition.